UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between copd and asthma clinical trials and research opportunities
A progressive lung condition affecting ~1.2 million diagnosed in the UK. Trials focus on inhaled therapies, biologics for exacerbation reduction, and pulmonary rehabilitation.
Affects ~5.4 million people in the UK. Biologic therapies (anti-IL5, anti-IgE) are transforming severe asthma treatment with active trial programmes.
COPD trials focus on symptom management and exacerbation prevention. Asthma trials increasingly target specific inflammatory phenotypes with precision biologics.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
